| Popis: |
Peritoneal dialysis (PD) is now an established and acceptable mode of treatment for end-stage renal failure. Whilst in short-term studies PD (3–5 years) has been shown to have a comparable outcome in terms of patient survival on haemodialysis [1–3], there are still concerns as to whether this mode of therapy can provide adequate treatment for end-stage renal disease in the longer term. Within the first 3–5 years, however, there is a considerable dropout rate from PD. This is principally due to episodes of peritonitis, loss of ultrafiltration or inadequate solute clearance [2–5]. |
